biotech investing

Strategic Acquisition and Capital Raising – Investor Presentation | 3

Read more

Significant Progress with B7-H3 Targeting Radio-Antibody (BetaBart)

Read more

Completion of Divesture of Non-US Assets

Read more

Appendix 4E and Preliminary Final Report – For the Year Ended 30 June 2024

Read more

Radiopharm Theranostics: Developing Innovative Radiopharmaceuticals for a

Read more

Cardiex June 2024 Quarter Update

Read more

Radiopharm Theranostics Targets Nasdaq Listing by End of 2024

Read more